Differentially expressed genes in cisplatin-induced premature ovarian failure in rats

Animal Reproduction Science

Volumn 137, Issue 3-4, 2013, Pages 205-213

  Li, Dong ^a   Chen, Yan ^a   Qi, Lei ^a   Ju, Xiuli ^a   Liu, Huan ^a   Wang, Guoyun ^a  

^a SHANDONG UNIVERSITY   (China)

Author keywords

Cisplatin; Gene expression; Inflammatory response; Premature ovarian failure; Reactive oxygen

Indexed keywords

CISPLATIN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; RNA;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DISEASE MODEL; DNA MICROARRAY; DRUG EFFECT; ESTRUS CYCLE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; ORGAN SIZE; PHYSIOLOGY; PREMATURE OVARIAN FAILURE; RANDOMIZATION; RAT; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BODY WEIGHT; CISPLATIN; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROUS CYCLE; FEMALE; FOLLICLE STIMULATING HORMONE; GENE EXPRESSION REGULATION; LUTEINIZING HORMONE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SIZE; PRIMARY OVARIAN INSUFFICIENCY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RNA;

ANIMALIA; RATTUS;

EID: 84875552477     PISSN: 03784320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.anireprosci.2012.11.011     Document Type: Article

References (37)

1. Conway G.S. Premature ovarian failure. Curr. Opin. Obstet. Gynecol. 1997, 9:202-206.
2. Coulam C.B., Adamson S.C., Annegers J.F. Incidence of premature ovarian failure. Obstet. Gynecol. 1986, 67:604-606.
3. Dahm-Kahler P., Runesson E., Lind A.K., Brannstrom M. Monocyte chemotactic protein-1 in the follicle of the menstrual and IVF cycle. Mol. Hum. Reprod. 2006, 12:1-6.
4. Fox H. The pathology of premature ovarian failure. J. Pathol. 1992, 167:357-363.
5. Frazer K.A., Murray S.S., Schork N.J., Topol E.J. Human genetic variation and its contribution to complex traits. Nat. Rev. Genet. 2009, 10:241-251.
6. Gery I., Gershon R.K., Waksman B.H. Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J. Exp. Med. 1972, 136:128-142.
7. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
8. Hurwitz A., Dushnik M., Solomon H., Ben-Chetrit A., Finci-Yeheskel Z., Milwidsky A., Mayer M., Adashi E.Y., Yagel S. Cytokine-mediated regulation of rat ovarian function: interleukin-1 stimulates the accumulation of a 92-kilodalton gelatinase. Endocrinology 1993, 132:2709-2714.
9. Karakji E.G., Tsang B.K. Regulation of rat granulosa cell plasminogen activator system: influence of interleukin-1 beta and ovarian follicular development. Biol. Reprod. 1995, 53:1302-1310.
10. Kim J.G., Moon S.Y., Chang Y.S., Lee J.Y. Autoimmune premature ovarian failure. J. Obstet. Gynaecol. (Tokyo 1995) 1995, 21:59-66.
11. Kokia E., Hurwitz A., Ricciarelli E., Tedeschi C., Resnick C.E., Mitchell M.D., Adashi E.Y. Interleukin-1 stimulates ovarian prostaglandin biosynthesis: evidence for heterologous contact-independent cell-cell interaction. Endocrinology 1992, 130:3095-3097.
12. Kruidering M., Van de Water B., de Heer E., Mulder G.J., Nagelkerke J.F. Cisplatin-induced nephrotoxicity in porcine proximal tubular cells: mitochondrial dysfunction by inhibition of complexes I to IV of the respiratory chain. J. Pharmacol. Exp. Ther. 1997, 280:638-649.
13. Lee H.J., Selesniemi K., Niikura Y., Niikura T., Klein R., Dombkowski D.M., Tilly J.L. Bone marrow transplantation generates immature oocytes and rescues long-term fertility in a preclinical mouse model of chemotherapy-induced premature ovarian failure. J. Clin. Oncol. 2007, 25:3198-3204.
14. Li X.A., Titlow W.B., Jackson B.A., Giltiay N., Nikolova-Karakashian M., Uittenbogaard A., Smart E.J. High density lipoprotein binding to scavenger receptor, Class B, type I activates endothelial nitric-oxide synthase in a ceramide-dependent manner. J. Biol. Chem. 2002, 277:11058-11063.
15. Lin M., Yin N., Murphy B., Medof M.E., Segerer S., Heeger P.S., Schroppel B. Immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes 2010, 59:2247-2252.
16. Lu Y., Cederbaum A.I. Cisplatin-induced hepatotoxicity is enhanced by elevated expression of cytochrome P450 2E1. Toxicol. Sci. 2006, 89:515-523.
17. Meirow D., Lewis H., Nugent D., Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum. Reprod. 1999, 14:1903-1907.
18. Meskhi A., Seif M.W. Premature ovarian failure. Curr. Opin. Obstet. Gynecol. 2006, 18:418-426.
19. Mizuta T., Kubokawa K. Presence of sex steroids and cytochrome P450 genes in amphioxus. Endocrinology 2007, 148:3554-3565.
20. Mollnes T.E., Song W.C., Lambris J.D. Complement in inflammatory tissue damage and disease. Trends Immunol. 2002, 23:61-64.
21. Nelson L.M. Clinical practice. Primary ovarian insufficiency. N. Engl. J. Med. 2009, 360:606-614.
22. Rigotti A., Trigatti B.L., Penman M., Rayburn H., Herz J., Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:12610-12615.
23. Robson H., Meyer S., Shalet S.M., Anderson E., Roberts S., Eden O.B. Platinum agents in the treatment of osteosarcoma: efficacy of cisplatin vs. carboplatin in human osteosarcoma cell lines. Med. Pediatr. Oncol. 2002, 39:573-580.
24. Rozman D., Cotman M., Frangez R. Lanosterol 14alpha-demethylase and MAS sterols in mammalian gametogenesis. Mol. Cell. Endocrinol. 2002, 187:179-187.
25. Seetharam D., Mineo C., Gormley A.K., Gibson L.L., Vongpatanasin W., Chambliss K.L., Hahner L.D., Cummings M.L., Kitchens R.L., Marcel Y.L., Rader D.J., Shaul P.W. High-density lipoprotein promotes endothelial cell migration and reendothelialization via scavenger receptor-B type I. Circ. Res. 2006, 98:63-72.
26. Shelling A. Progress in the study of genetic disease: bringing new light to complex problems. Postgrad. Med. J. 2009, 85:505-507.
27. Shelling A.N. Premature ovarian failure. Reproduction 2010, 140:633-641.
28. Simpson J.L. Genetic and phenotypic heterogeneity in ovarian failure: overview of selected candidate genes. Ann. N. Y. Acad. Sci. 2008, 1135:146-154.
29. Swarnakar S., Temel R.E., Connelly M.A., Azhar S., Williams D.L. Scavenger receptor class B, type I, mediates selective uptake of low density lipoprotein cholesteryl ester. J. Biol. Chem. 1999, 274:29733-29739.
30. Townson D.H., O'Connor C.L., Pru J.K. Expression of monocyte chemoattractant protein-1 and distribution of immune cell populations in the bovine corpus luteum throughout the estrous cycle. Biol. Reprod. 2002, 66:361-366.
31. Wallace W.H., Thomson A.B., Kelsey T.W. The radiosensitivity of the human oocyte. Hum. Reprod. 2003, 18:117-121.
32. Wang C., Xu B., Zhou B., Zhang C., Yang J., Ouyang H., Ning G., Zhang M., Shen J., Xia G. Reducing CYP51 inhibits follicle-stimulating hormone induced resumption of mouse oocyte meiosis in vitro. J. Lipid Res. 2009, 50:2164-2172.
33. Wang X., Lu Y., Cederbaum A.I. Induction of cytochrome P450 2E1 increases hepatotoxicity caused by Fas agonistic Jo2 antibody in mice. Hepatology (Baltimore, Md.) 2005, 42:400-410.
34. Wang Y., Gray J.P., Mishin V., Heck D.E., Laskin D.L., Laskin J.D. Distinct roles of cytochrome P450 reductase in mitomycin C redox cycling and cytotoxicity. Mol. Cancer Ther. 2010, 9:1852-1863.
35. Wessels M.R., Butko P., Ma M., Warren H.B., Lage A.L., Carroll M.C. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:11490-11494.
36. Woad K.J., Watkins W.J., Prendergast D., Shelling A.N. The genetic basis of premature ovarian failure. Aust. N. Z. J. Obstet. Gynaecol. 2006, 46:242-244.
37. Yang B.H., Parkin D.M., Cai L., Zhang Z.F. Cancer burden and trends in the Asian Pacific Rim region. Asian. Pac. J. Cancer Prev. 2004, 5:96-117.